The Cholinergic Brain in Parkinson's Disease
- PMID: 34631936
- PMCID: PMC8485627
- DOI: 10.1002/mdc3.13319
The Cholinergic Brain in Parkinson's Disease
Abstract
The central cholinergic system includes the basal forebrain nuclei, mainly projecting to the cortex, the mesopontine tegmental nuclei, mainly projecting to the thalamus and subcortical structures, and other groups of projecting neurons and interneurons. This system regulates many functions of human behavior such as cognition, locomotion, and sleep. In Parkinson's disease (PD), disruption of central cholinergic transmission has been associated with cognitive decline, gait problems, freezing of gait (FOG), falls, REM sleep behavior disorder (RBD), neuropsychiatric manifestations, and olfactory dysfunction. Neuropathological and neuroimaging evidence suggests that basal forebrain pathology occurs simultaneously with nigrostriatal denervation, whereas pathology in the pontine nuclei may occur before the onset of motor symptoms. These studies have also detailed the clinical implications of cholinergic dysfunction in PD. Degeneration of basal forebrain nuclei and consequential cortical cholinergic denervation are associated with and may predict the subsequent development of cognitive decline and neuropsychiatric symptoms. Gait problems, FOG, and falls are associated with a complex dysfunction of both pontine and basal forebrain nuclei. Olfactory impairment is associated with cholinergic denervation of the limbic archicortex, specifically hippocampus and amygdala. Available evidence suggests that cholinergic dysfunction, alongside failure of the dopaminergic and other neurotransmitters systems, contributes to the generation of a specific set of clinical manifestations. Therefore, a "cholinergic phenotype" can be identified in people presenting with cognitive decline, falls, and RBD. In this review, we will summarize the organization of the central cholinergic system and the clinical correlates of cholinergic dysfunction in PD.
Keywords: Parkinson's disease; basal forebrain; cholinergic; dementia; falls.
© 2021 International Parkinson and Movement Disorder Society.
Conflict of interest statement
The authors declare that they did not receive specific funding for this work. The authors declare that there are no conflicts of interest relevant to this work.
Figures

Similar articles
-
[Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].Glas Srp Akad Nauka Med. 2011;(51):85-97. Glas Srp Akad Nauka Med. 2011. PMID: 22165729 Review. Serbian.
-
The involvement of the cholinergic system in Parkinson disease.Handb Clin Neurol. 2025;211:215-229. doi: 10.1016/B978-0-443-19088-9.00001-9. Handb Clin Neurol. 2025. PMID: 40340062 Review.
-
Cholinergic basal forebrain degeneration in isolated REM sleep behaviour disorder.Brain. 2025 May 26:awaf196. doi: 10.1093/brain/awaf196. Online ahead of print. Brain. 2025. PMID: 40417772
-
In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.Brain. 2018 Jan 1;141(1):165-176. doi: 10.1093/brain/awx310. Brain. 2018. PMID: 29228203 Free PMC article.
-
Cholinergic basal forebrain and hippocampal structure influence visuospatial memory in Parkinson's disease.Brain Imaging Behav. 2022 Feb;16(1):118-129. doi: 10.1007/s11682-021-00481-0. Epub 2021 Jun 26. Brain Imaging Behav. 2022. PMID: 34176042
Cited by
-
Molecular Imaging in Parkinsonian Disorders-What's New and Hot?Brain Sci. 2022 Aug 27;12(9):1146. doi: 10.3390/brainsci12091146. Brain Sci. 2022. PMID: 36138882 Free PMC article. Review.
-
The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson's Disease.Mol Neurobiol. 2024 Nov;61(11):9078-9109. doi: 10.1007/s12035-024-04151-2. Epub 2024 Apr 8. Mol Neurobiol. 2024. PMID: 38587699 Review.
-
Advances in research on the pathogenesis and signaling pathways associated with postoperative delirium (Review).Mol Med Rep. 2025 Aug;32(2):220. doi: 10.3892/mmr.2025.13585. Epub 2025 Jun 6. Mol Med Rep. 2025. PMID: 40476568 Free PMC article. Review.
-
Cholinergic dysfunction in isolated rapid eye movement sleep behaviour disorder links to impending phenoconversion.Eur J Neurol. 2024 Dec;31(12):e16503. doi: 10.1111/ene.16503. Epub 2024 Oct 3. Eur J Neurol. 2024. PMID: 39360592 Free PMC article.
-
Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l-DOPA-induced dyskinetic behaviors.Sci Adv. 2024 Nov 22;10(47):eadp6301. doi: 10.1126/sciadv.adp6301. Epub 2024 Nov 20. Sci Adv. 2024. PMID: 39565858 Free PMC article.
References
-
- Mesulam MM, Mufson EJ, Wainer BH, Levey AI. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1‐Ch6). Neuroscience 1983;10(4):1185–1201. - PubMed
-
- Lewy FH. Pathologischen Anatomie der Paralysis Agitans. Dtsch Z Nervenheilk 1913;50:50–55.
-
- Benagiano V, Virgintino D, Flace P, Girolamo F, Errede M, Roncali L, Ambrosi G. Choline acetyltransferase‐containing neurons in the human parietal neocortex. Eur J Histochem 2003;47(3):253–256. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources